These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 24747869)
1. Enhanced chemopreventive effects of a hydrogen sulfide-releasing anti-inflammatory drug (ATB-346) in experimental colorectal cancer. Elsheikh W; Blackler RW; Flannigan KL; Wallace JL Nitric Oxide; 2014 Sep; 41():131-7. PubMed ID: 24747869 [TBL] [Abstract][Full Text] [Related]
2. Profound Chemopreventative Effects of a Hydrogen Sulfide-Releasing NSAID in the APCMin/+ Mouse Model of Intestinal Tumorigenesis. Paul-Clark M; Elsheikh W; Kirkby N; Chan M; Devchand P; Agbor TA; Flannigan KL; Cheadle C; Freydin M; Ianaro A; Mitchell JA; Wallace JL PLoS One; 2016; 11(2):e0147289. PubMed ID: 26910063 [TBL] [Abstract][Full Text] [Related]
3. Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346). Wallace JL; Caliendo G; Santagada V; Cirino G Br J Pharmacol; 2010 Mar; 159(6):1236-46. PubMed ID: 20128814 [TBL] [Abstract][Full Text] [Related]
4. ATB-346, a novel hydrogen sulfide-releasing anti-inflammatory drug, induces apoptosis of human melanoma cells and inhibits melanoma development in vivo. De Cicco P; Panza E; Ercolano G; Armogida C; Sessa G; Pirozzi G; Cirino G; Wallace JL; Ianaro A Pharmacol Res; 2016 Dec; 114():67-73. PubMed ID: 27777130 [TBL] [Abstract][Full Text] [Related]
5. A hydrogen sulfide-releasing cyclooxygenase inhibitor markedly accelerates recovery from experimental spinal cord injury. Campolo M; Esposito E; Ahmad A; Di Paola R; Wallace JL; Cuzzocrea S FASEB J; 2013 Nov; 27(11):4489-99. PubMed ID: 23901068 [TBL] [Abstract][Full Text] [Related]
6. The effect of hydrogen sulfide-releasing naproxen (ATB-346) versus naproxen on formation of stress-induced gastric lesions, the regulation of systemic inflammation, hypoxia and alterations in gastric microcirculation. Magierowski M; Magierowska K; Surmiak M; Hubalewska-Mazgaj M; Kwiecien S; Wallace JL; Brzozowski T J Physiol Pharmacol; 2017 Oct; 68(5):749-756. PubMed ID: 29375050 [TBL] [Abstract][Full Text] [Related]
7. Chemoprevention of colonic aberrant crypt foci by Gynura procumbens in rats. Shwter AN; Abdullah NA; Alshawsh MA; Alsalahi A; Hajrezaei M; Almaqrami AA; Salem SD; Abdulla MA J Ethnopharmacol; 2014 Feb; 151(3):1194-1201. PubMed ID: 24393787 [TBL] [Abstract][Full Text] [Related]
8. Deciphering the pathogenesis of NSAID enteropathy using proton pump inhibitors and a hydrogen sulfide-releasing NSAID. Blackler RW; De Palma G; Manko A; Da Silva GJ; Flannigan KL; Bercik P; Surette MG; Buret AG; Wallace JL Am J Physiol Gastrointest Liver Physiol; 2015 Jun; 308(12):G994-1003. PubMed ID: 25882612 [TBL] [Abstract][Full Text] [Related]
9. Effects of dark chocolate on azoxymethane-induced colonic aberrant crypt foci. Hong MY; Nulton E; Shelechi M; Hernández LM; Nemoseck T Nutr Cancer; 2013; 65(5):677-85. PubMed ID: 23859035 [TBL] [Abstract][Full Text] [Related]